Death of a clinical trial: a speculative inclusion criterion gone wrong

Intern Med J. 2007 Dec;37(12):838-9. doi: 10.1111/j.1445-5994.2007.01542.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Australia
  • Chemotherapy, Adjuvant
  • Diphosphonates / therapeutic use
  • Docetaxel
  • Humans
  • Imidazoles / therapeutic use
  • Male
  • Multicenter Studies as Topic
  • Neoplasm Recurrence, Local*
  • Prostate-Specific Antigen / blood
  • Prostatectomy*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / surgery*
  • Randomized Controlled Trials as Topic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Taxoids / therapeutic use
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Imidazoles
  • Taxoids
  • Docetaxel
  • Zoledronic Acid
  • Prostate-Specific Antigen